We are live on ! Find out more
PLXP

PLx Pharma Inc. Common Stock

Delisted

PLXP was delisted on the 12th of April, 2023.

15 hedge funds and large institutions have $6.51M invested in PLx Pharma Inc. Common Stock in 2020 Q3 according to their latest regulatory filings, with 1 funds opening new positions, 4 increasing their positions, 2 reducing their positions, and 4 closing their positions.

New
Increased
Maintained
Reduced
Closed

100% more repeat investments, than reductions

Existing positions increased: 4 | Existing positions reduced: 2

0% less capital invested

Capital invested by funds: $6.52M → $6.51M (-$6.52K)

17% less funds holding

Funds holding: 1815 (-3)

75% less first-time investments, than exits

New positions opened: 1 | Existing positions closed: 4

100% less funds holding in top 10

Funds holding in top 10: 10 (-1)

Holders
15
Holders Change
-3
Holders Change %
-16.67%
% of All Funds
0.3%
Holding in Top 10
Holding in Top 10 Change
-1
Holding in Top 10 Change %
-100%
% of All Funds
New
1
Increased
4
Reduced
2
Closed
4
Calls
Puts
Net Calls
Net Calls Change

PLXP Hedge Fund Activity: Q3 2020 in Review

15 of the 4,956 institutional investors tracked by Wall St. Rank reported a position in PLx Pharma Inc. Common Stock (PLXP) for Q3 2020, worth a combined $6.51M — down 0.1% from $6.52M a quarter earlier.

Sellers outnumbered buyers: 4 funds closed out of PLXP and 1 opened new positions — a net loss of 3 holders — while 2 trimmed existing stakes and 4 added.

The largest buyer was Brown Advisory, opening a new position worth an estimated $116K. The largest seller was Millennium Management, cutting an estimated $3.87K.

  • 15 institutional investors held PLx Pharma Inc. Common Stock (PLXP) as of Q3 2020, down from 18 in Q2 2020.
  • Funds reported $6.51M of PLx Pharma Inc. Common Stock stock for Q3 2020, down 0.1% quarter-over-quarter.
  • 1 fund opened new PLx Pharma Inc. Common Stock positions in Q3 2020 and 4 closed out, a net change of -3 holders.
  • The largest PLx Pharma Inc. Common Stock buyer in Q3 2020 was Brown Advisory, an estimated $116K added.
  • The largest PLx Pharma Inc. Common Stock seller in Q3 2020 was Millennium Management, an estimated $3.87K sold.

Based on aggregated 13F filings for Q3 2020.